Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 21, 407-421, April 1, 1961]
© 1961 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wheeler, G. P.
Right arrow Articles by Alexander, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wheeler, G. P.
Right arrow Articles by Alexander, J. A.

Searches for Exploitable Biochemical Differences between Normal and Cancer Cells. VIII. Catabolism of Purines and Purine Nucleotides by Sonicates*

Glynn P. Wheeler and Jo Ann Alexander

( Kettering-Meyer Laboratory,{dagger} Southern Research Institute, Birmingham, Ala.)

Radioactive purines and purine ribonucleotides were incubated with sonicates of mouse liver, mouse intestine, Adenocarcinoma 755, Sarcoma 180, Leukemia L1210, rat liver, rat intestine, and Novikoff hepatoma, and the residual substrates and the products of catabolism were isolated with the aid of paper chromatography and radioautography. Less catabolism occurred with the tumors than with the livers and intestines, and analysis of the data led to the conclusion that the decreased catabolism was primarily due to decreased xanthine oxidase activity.

* This work was supported by the Cancer Chemotherapy National Service Center, National Cancer Institute, under the National Institutes of Health Contract No. SA-43-ph-2433, and by grants from the Charles F. Kettering Foundation and the Alfred P. Sloan Foundation.

{dagger} Affiliated with Sloan-Kettering Institute for Cancer Research, New York, N.Y.

Received 10/14/60.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1961 by the American Association for Cancer Research.